Background and objectives: Adverse drug reactions (ADRs) are recognized as a common cause of hospital admissions and they constitute a significant economic burden for the hospitals. Many disasters caused by drugs occurred in the past, after that regulation for drug approval has taken place. The aim of this study was to evaluate ADRs and assess their causality, severity and preventability in Erbil and Duhok main hospitals. Methods: This is a retrospective cross-sectional, hospital-based study, conducted at Rizgary hospital in Erbil and Azadi hospital in Duhok from January to October 2016. Each Adverse reaction was assessed for its causality, severity and preventability using Naranjo, Hartwig and Siegel, and Schumock and Thornton assessment scales, respectively. Data were analyzed using descriptive analysis. Results: A total of 378 patients with ADRs were reported, 57.7% females and 42.3% males. The maximum percentage of ADRs was noted in patient's age 21-40 years, 66.4% occurred in patients taking two or more medications. Common ADRs were allergic reactions (30.2%) and these involved with the gastrointestinal tract (20.6%). Antimicrobials (30.7%) and analgesics (9.0%) were the common causes of ADRs. Oral (49.47%) and intravenous (37.30%) routes of drug administration were responsible for most of ADRs. Of these cases, 47.9% were preventable, of moderate severity (52.9%), while 7.7% hospitalized, 1.1% needed surgical intervention and 2.4% died from ADRs. Conclusions: ADRs can be frequently detected; they increase cost of treatment although about half can be prevented. These problems are essential to be reported, analyzed and interpreted, then effectively communicated with health authorities. Duhok Med J 2017; 11 (1): 19-32.
he word pharmacovigilance (PV) has been derived from the Greek word pharmacon which means "drug" and the Latin word vigilare means "to keep awake or alert, to keep watch". 1 World Health
Organization (WHO) defines PV as "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem". 2 A simpler definition describes PV as the processes and science of monitoring drugs safety and taking action to reduce risk and increase benefit. 3, 4 Historically, there are multitudes of examples of patients harmed by the use of prescribed medications. The thalidomide tragedy is one of the worst examples, Prior to product registration and marketing, drugs safety and efficacy information are restricted to observations from pre-clinical animal studies and initial clinical trials (Phase I-III) and these data comprise the basis for the summary of product characteristics or the product label. 8 Although such trials are appropriate for product registration, they usually evaluate only a small number of selected participants under ideal conditions and have limited statistical power to detect the uncommon side effects. As a result, clinical trials and the data that is derived from them are insufficient for the full evaluation of product safety and risks. 9 Additionally, such trials better test the efficacy rather than the safety under the practical conditions of every day clinical utilization.
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Adverse drug reactions are common, often preventable cause of illness, disability and even death. They cause from 3% to 6% of hospital admissions at any age, and up to 24% in the elderly population; they rank fifth among all causes of death, representing from 5 to 10% of hospital costs.
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In order to prevent or reduce harm to the patients and improve health, mechanisms for evaluating and monitoring the drug safety in clinical use are crucial. The aim of this study was to evaluate ADRs and assessing their causality, severity and preventability in Erbil and Duhok main hospitals and to facilitate the development of a pharmacovigilance service in Kurdistan Region-Iraq.
PATIENTS AND METHODS
A retrospective cross-sectional study was conducted during the period from January to October of 2016. The study was performed in two main tertiary care teaching hospitals located in Kurdistan Region of Iraq, Rizgary hospital in Erbil and Azadi hospital in Duhok.
The study involved all departments in the two hospitals and included inpatients who experienced any ADRs in the hospital or those who were admitted for treatment of ADRs. Patients admitted solely for investigations or with incomplete or unclear medical information were excluded from the study. During the study period, patients were reviewed for ADRs, especially for new drug and the unusual or unexpected reactions. Orientation about the study is being offered for healthcare practitioners (including physicians, pharmacists and nurses) and all of them were asked to report any observed ADRs. Patients with the offending drugs were identified through routine ward rounds, prescription monitoring, and healthcare practitioners reports. The data were collected from patient case sheets and transferred to a separate data entry formats ( Figure 1 ) specially designed for reporting ADRs. Data were then analyzed by using Naranjo's causality assessment scale, Hartwig and Siegel severity assessment scale, and Schumock and Thornton preventability assessment scale. All patients with suspected/detected ADRs were referred to respective physician to confirm the diagnosis. We designed a template ( Figure 1 ) for reporting ADR containing the main information needed according to WHO and FDA criteria 10, 12 to identify the main medical problems related to the drug preparation in use including information about the patient, suspected drug(s), adverse reaction and the reporter. The causality assessment scale examined the relation between the reaction and the suspected drug(s) taken by the patient by using the Naranjo Algorithm (Table 1) . The severity assessment scale measured and scored the severity of each reaction according to the scale commonly used in the ADRs assessment which is Hartwig and Siegel severity scale ( 
Level 6
The adverse reaction caused permanent harm to the patient.
Level 7
The adverse reaction either directly or indirectly led to the death of the patient.
The preventability assessment comes after the reaction causality and severity have been determined to examine if the ADR could be prevented or not by using Schumock and Thornton preventability assessment scale 15 (Table 3) . The percentage of ADRs was 33.6% in patients taking single medication, whereas 66.4% of ADRs occurred in patients taking two or more medications concomitantly (Table 5 ). (Table 6 ). (Table 7) . Antimicrobials were associated with approximately one-third of all ADRs reported (30.7%) followed by analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) which were associated with 9.0% of ADRs. The routes of drug administration in relation to ADRs are shown in Figure 2 . Approximately half of ADRs were noted with the oral route. Drugs that were administered by intravenous (IV) route accounted for 37.30% of ADRs, whereas topically administered drugs caused only 1.56% of ADRs. The dosage form which most commonly implicated in ADRs was the tablet form (39.7%); followed by injectable formulation in vials (29.4%). Only 4 cases (1.1%) were caused by cream use. The distribution of different dosage forms among reported therapeutic drug classes and organ systems affected are shown in Figure 3 . Upon causality assessment using Naranjo's algorithm, majority of the ADRs were rated as probable (57.9%), only 0.5% were considered as doubtful, 14.6% possible, and 27.0% were classified as definite ADRs (Table 8) . Based on Hartwig and Siegel scale to evaluate the severity of ADRs, it was evident that most of ADRs reported in the study were of moderate severity (52.9%), 34.1% were of mild severity and 13.0% of ADRs were severe (Table 9 ). On evaluation of the chances of preventability of ADRs using Schumock and Thornton scale, it was evident that about half of ADRs were preventable (Table 10) . (Figure 4 ). In 248 (65.6%) of cases, the suspected drug was withdrawn and one or more drugs were required for symptomatic or specific treatment, whereas no change was needed with the suspected drug in 61 (16.1%) of the cases. Also, in 143 (37.8%) of cases, ADRs increased patient's hospital stay by at least one day.
DISCUSSION
Events such as the thalidomide tragedy highlighted the extreme need for effective drug monitoring systems of all drugs. Safety monitoring of drugs in common use should be an integral part of clinical practice. There is no agreement among studies regarding the incidence of ADRs with respect to gender 16 . Rademaker (2001) reported that females were more susceptible to ADRs, the reasons for this increased risk are not completely clear but include gender-related differences in pharmacokinetic, immunological and hormonal factors. 17 Others have found the incidence of ADRs to be unrelated to gender, 16 18 which support our finding that ADRs did not differ significantly between males and females ( 
ADVERSE DRUG REACTIONS MONITORING: A PHARMACOVIGILANCE
In our study the majority of ADRs were in 21-40 years age group (Table 4) . The reason might be attributed to modern sedentary lifestyle and increased stress in daily life make this age group more prone to diseases. 19 So it is anticipated that this age group used drugs more frequently and repeatedly visited the hospital for their regular check-up and complaints for drug related adverse effects. The incidence of ADRs was not directly proportional to the number of drugs being taken but increases remarkably as the number of drugs rises; it could be attributed to drug-drug and drug-disease interactions. 20 This was observed in our study in table 5 . Moreover, we found that allergic reactions were the most frequent ADRs detected (Table 6 ). This finding is in accordance with the results of a previous study done by Patidar et al. (2013) 21 but it differs from those of others where gastrointestinal (GI) manifestations had the highest rate.
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In our study, the GI system was the second most frequent cause of ADRs. The reason for this could be that we had given a great attention to detect unusual or uncommon ADRs which were observed in our study. Drugs most frequently trigger allergic reactions were antimicrobial agents and NSAIDs. 22 In this study, the drug class most commonly implicated with ADRs was antimicrobials with the highest percentage, followed by analgesic and NSAIDs (Table 7) . A similar finding was reported by Malladi (2016).
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Majority of the ADRs were associated with oral route of drug administration followed by parenteral then topical route ( Figure 2 ) as reported by Shrivastava et al.
(2011). 24 One of the possible explanations is that the most frequent organ system affected by ADRs were GI tract and allergic reactions, ADRs on the GI tract were most commonly observed with oral medications, 19 whereas most of the ADRs observed with injectable medication were hypersensitivity reaction, as the parenteral route is considered the most immunogenic one.
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To strengthen and further emphasize the validity of the findings of our study, causality assessment was done by using the Naranjo's scale ( On evaluation of the ADRs severity by the Hartwig and Siegel severity assessment scale (Table 2) , it was clear that most of ADRs reported in this study were of moderate severity followed by mild then severe (Table 9 ). However another study found that the majority of the reactions were moderate in severity, 27 whereas others reported that most of the reactions were of mild severity. 28 This could be attributed to different ADRs of varying degrees of severity can be caused by various drug types and formulations used by the patients. On evaluation of the chances of preventability of ADRs using Schumock and Thornton scale (Table 3) , it was evident that about half (47.9%) of the reactions were preventable (Table 10) . Some of those preventable cases have a previous history of similar reaction following same drug intake; which shows the lack of awareness. Our result was consistence with another study that measured the preventability of ADRs at four hospitals in South Africa, 29 and with a meta-analysis study which also found that approximately half of adverse drug reactions are preventable, demonstrating that further evidence on prevention strategies is required. 30 Some researchers found that only little percentage of the ADRs can be prevented.
31,32
Others reported that most of the ADRs were definitely preventable. 33 In the last study the occurrence of ADRs was higher when compared to that reported in other studies, so preventability of ADRs may differ from one study to another depending on different factors and most resulted from inadequate monitoring of therapy or inappropriate dosing.
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Our results on the hospital admission caused by ADRs were comparable to results obtained by researchers who reviewed 45 studies for the prevalence rates of hospitalization resulting from ADRs. 35 In the present study, 2.4% of all ADRs had fatal effect on the patients and this finding is in accordance with the result of a review article that found that the rate of fatal ADRs among a 47 studies was quite consistent, 36 and 66.9% of the patient were recovered from the reaction ( Figure  4 ), as shown in another study.
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The impact and the management of ADRs will increase the costs per patient due to increased hospitalization, prolongation of hospital stay, additional clinical investigations and prescription of new drug for the patient condition. 38 Most of ADRs cases in our study required withdrawal of the suspected drug and one drug or more was needed for symptomatic or specific treatment, with low percentages that required no change in treatment. These results were comparable to the results of another study.
21
In the present study the length of hospital stay was prolonged in 37.8% of ADRs affected patient by at least one day. This is confirmed by Davies et al. (2009) study who concluded that there is a direct relationship between ADRs and the length of patient hospital stay.
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Moreover another study showed that the severity of adverse drug events was also associated with higher costs and a longer length of stay therefore adverse drug events could be economically costly.
40
Adverse drug reactions were frequently detected in the main teaching hospitals in Kurdistan Region of Iraq. Some cause hospital admissions, intensive medical care and even death; all increases cost of treatment although about half can be prevented. These problems are essential to be reported, analyzed and interpreted then effectively communicated. 
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